Crystal's MCW Coder HubCPT 50800 - Ureteroenterostomy, Direct Anastomosis of Ureter to Intestine
Short Descriptor
Ureteroenterostomy; direct anastomosis of ureter to intestine
Full Descriptor
Ureteroenterostomy, direct anastomosis of ureter to intestine
This code describes the surgical creation of a new connection (anastomosis) between the ureter and a segment of the intestine to divert urine from its natural pathway into the gastrointestinal tract or an intestinal conduit. It is performed via an open surgical approach and represents the most direct form of ureteral-to-bowel diversion, typically reserved for cases where the urinary bladder has been removed, is severely damaged, or is bypassed due to a life-limiting obstructive or oncologic condition.
Code Tree / Hierarchy
Surgery (10000-69999)
└── Urinary System (50010-53899)
└── Ureter (50010-50980)
└── Repair Procedures on the Ureter (50700-50860)
├── 50700 - Ureteroplasty, plastic operation on ureter
├── 50715 - Ureterolysis, with or without repositioning
├── 50722 - Ureterolysis for ovarian vein syndrome
├── 50725 - Ureterolysis for retroperitoneal fibrosis
├── 50727 - Revision of urinary-cutaneous anastomosis
├── 50728 - Revision of urinary-cutaneous anastomosis; with repair of fascial defect
├── 50740 - Ureteropyelostomy
├── 50750 - Ureterocalycostomy
├── 50760 - Ureteroureterostomy
├── 50770 - Transureteroureterostomy
├── 50780 - Ureteroneocystostomy; anastomosis of single ureter to bladder
├── 50782 - Ureteroneocystostomy; anastomosis of duplicated ureter to bladder
├── 50783 - Ureteroneocystostomy; with extensive ureteral tailoring
├── 50785 - Ureteroneocystostomy; with psoas hitch or Boari flap
├── 50800 - Ureteroenterostomy ✅ ← THIS CODE
├── 50810 - Ureterocolon conduit (Goodwin pouch)
├── 50815 - Ureterocolic conduit; with sigmoid reservoir
├── 50820 - Ureteroileal conduit (Bricker procedure)
├── 50825 - Continent diversion, not associated with cystectomy
├── 50830 - Urinary undiversion (any type)
└── 50860 - Ureterostomy, transplantation of ureter to skin
Clinical Overview
CPT 50800 describes an open surgical ureteroenterostomy — the direct anastomosis (connection) of one or both ureters to a segment of the intestine. This procedure diverts urine from the kidney through the ureter directly into the bowel rather than the bladder. The urine then mixes with and exits through the patient’s gastrointestinal tract, most commonly the sigmoid colon.
This technique is the oldest form of urinary diversion and is distinct from conduit-based diversions (like the Bricker ureteroileal conduit, CPT 50820) in that the ureter is connected directly to the native bowel without creation of a separate intestinal reservoir or stoma.
Primary Clinical Indications
- Bladder extrophy or other severe congenital anomalies of the lower urinary tract
- Loss of the urinary bladder following total or radical cystectomy when a conduit-based or continent diversion is not feasible
- Urinary fistulae involving the bladder that cannot be repaired
- Severe pelvic trauma with destruction of the bladder and proximal urethra
- Radiation-induced vesicointestinal fistula where bladder reconstruction is impossible
- Neurogenic bladder with failed prior surgical options in select patients
- Ureteral obstruction by pelvic malignancy where direct reanastomosis is the only viable option
Surgical Technique Overview
- Patient is positioned supine or in modified lithotomy depending on associated procedures
- A laparotomy incision (midline, Pfannenstiel, or flank depending on anatomy) is made
- The ureter(s) is (are) identified, mobilized, and divided at the appropriate level
- A site on the bowel wall (most commonly sigmoid colon) is selected for anastomosis
- A small enterotomy (opening) is made in the bowel at the selected site
- The ureter is directly sutured to the bowel opening in a watertight, tension-free anastomosis using absorbable sutures (often with mucosa-to-mucosa technique)
- Ureteral stents may be placed across the anastomosis to maintain patency during healing
- The retroperitoneum is closed to prevent internal hernias
- Drains are placed and the abdomen is closed in layers
⚠️ Metabolic Note: Urine contact with the intestinal mucosa leads to electrolyte reabsorption (hyperchloremic metabolic acidosis) and potential for ascending infection. This is the principal long-term metabolic complication of direct ureterosigmoidostomy and one reason more modern diversion techniques (ileal conduits, continent pouches) have largely replaced the direct ureteroenterostomy in most centers.
Includes - Bundled Services
The following services are considered integral components of CPT 50800 and must NOT be separately reported when performed as part of the same surgical session:
| Bundled Service | CPT Code(s) | Notes |
|---|---|---|
| Cystourethroscopy (diagnostic) | 52000 | Standard inspection of the lower urinary tract prior to or during open repair is included |
| Ureteral catheterization/stent placement intraoperatively | 52005, 52332 | Placement of a temporary ureteral stent as part of the anastomosis is not separately billable |
| Mobilization and lysis of ureter | 50715 | Ureterolysis required to achieve tension-free anastomosis is integral |
| Enterotomy and closure | — | The bowel incision made to accommodate the ureter is integral to the anastomosis |
| Basic hemostasis and drain placement | — | Routine wound closure and drain placement are included in the global surgical package |
| Retroperitoneal dissection for exposure | — | Surgical exposure required to access the ureter is integral |
⚠️ Do NOT separately bill 50715 (ureterolysis) when ureterolysis is performed solely to mobilize the ureter for the 50800 anastomosis. If ureterolysis is performed as a distinct, medically independent procedure for retroperitoneal fibrosis or other separate indication, document distinctness clearly and consider modifier -59 / -XE after verifying NCCI edits.
Related & Excluded CPT Codes
| CPT | Description | Relationship to 50800 |
|---|---|---|
| 50810 | Ureterocolon conduit (sigmoid pouch; Goodwin) | Sibling code - uses sigmoid colon as a reservoir/conduit vs. direct anastomosis |
| 50815 | Ureterocolic conduit with sigmoid reservoir | Sibling code - more complex variant with sigmoid reservoir formation |
| 50820 | Ureteroileal conduit (Bricker procedure) | Most common urinary diversion in modern practice; uses ileal segment; distinct from 50800 |
| 50825 | Continent diversion, not associated with cystectomy | Continent internal reservoir (e.g., Indiana pouch) without cystectomy |
| 50830 | Urinary undiversion | Reversal of prior diversion procedure |
| 50860 | Ureterostomy to skin (cutaneous ureterostomy) | Ureter brought directly to skin - no bowel involved |
| 50780 | Ureteroneocystostomy - single ureter to bladder | Reimplantation of ureter into bladder - entirely different target organ |
| 51590 | Cystectomy with ureteroileal or sigmoid bladder | Includes cystectomy + conduit - when cystectomy is performed as part of the same session, 51590 is used instead of 50800 + 51570 |
| 51595 | Cystectomy + ureteroileal conduit + bilateral pelvic lymphadenectomy | Includes all three components; do NOT add 50800 or 50820 when 51595 is used |
| 51596 | Cystectomy with continent diversion | All-inclusive code when cystectomy + continent diversion performed together |
| 51570 | Cystectomy, complete | When cystectomy is performed WITHOUT a concurrent diversion - pair with 50800 if diversion also performed and not covered by 51590 |
| 38770 | Bilateral pelvic lymphadenectomy | May be separately reported when cystectomy and diversion do not include lymphadenectomy (verify NCCI) |
| 88305 | Surgical pathology - gross and microscopic | Separately billable by pathology for any tissue specimens sent |
| 74420-26 | Urography, retrograde - professional component | May be separately billable for radiologic guidance if performed by a separate radiologist |
Note
💡 Key Distinction: CPT 50800 is used when the ureter is anastomosed directly to the native bowel (typically sigmoid colon) without construction of an isolated intestinal segment or pouch. When an ileal conduit (Bricker) is created from an isolated ileal segment, use 50820. When performed with a complete cystectomy, use the combined cystectomy-diversion codes (51590, 51595, 51596) instead of stacking 50800 with a cystectomy code — these are mutually exclusive.
RVU & Reimbursement (2026)
All values are national averages before Geographic Practice Cost Index (GPCI) adjustments. Verify exact 2026 values via the CMS MPFS Lookup Tool at cms.gov/medicare/physician-fee-schedule/search. The 2026 CMS Final Rule applied a -2.5% efficiency adjustment to non-time-based surgical codes, which affects 50800.
Physician Fee Schedule (Professional Component)
| Metric | Value | Notes |
|---|---|---|
| wRVU - 2026 (Estimated, Post-Adjustment) | ~18.08 | 2025 baseline ~18.53 less ~2.5% efficiency adjustment; verify via CMS MPFS |
| wRVU - 2025 Baseline | ~18.53 | Pre-2026 efficiency revaluation |
| Estimated Facility Physician Payment (National) | ~$607 | ~18.08 × $33.57; before GPCI |
| CMS 2026 Conversion Factor (Qualifying APM) | $33.57 | +3.77% from 2025 |
| CMS 2026 Conversion Factor (Non-Qualifying APM) | $33.40 | +3.26% from 2025 |
| Global Period | 090 days | Major surgery global package |
| Multiple Procedure Indicator | 2 | Subject to standard multiple procedure reduction (50% on lower-valued procedure) |
| Bilateral Surgery Indicator | Modifier 50 applicable | When both ureters are anastomosed; append modifier -50; second side paid at 50% of primary |
Note
⚠️ Always verify the final CMS 2026 wRVU for CPT 50800 directly from the CMS MPFS ZIP file (PFS_0126_NFRVU.xlsx or current equivalent) as this procedure may have been subject to individual revaluation beyond the blanket efficiency adjustment.
Facility / Inpatient Context
| Setting | Typical MS-DRG | Reimbursement Driver |
|---|---|---|
| Inpatient - Bladder cancer + cystectomy | 652 / 653 / 654 | Principal DRG MDC 11 Major Bladder Procedures |
| Inpatient - Ureteral neoplasm | 659 / 660 / 661 | DRG MDC 11 Kidney & Ureter Procedures for Neoplasm |
| Inpatient - Non-neoplasm indication | 656 / 657 / 658 | DRG MDC 11 Kidney & Ureter Procedures for Non-Neoplasm |
Note
This procedure is almost exclusively performed in the inpatient setting given its complexity, the need for bowel preparation, extended recovery time, and management of postoperative complications (metabolic acidosis, anastomotic leak, infection). Outpatient billing (HOPD/ASC) would be atypical and would require strong documentation of appropriateness.
Global Period & Post-Op Billing
- Global Period: 090 days (major surgery)
- Pre-operative E/M on day of surgery: Included in the global package unless it represents a significant, separately identifiable service for a separate condition (append modifier -25 to the E/M code)
- Post-operative visits (90 days): Included — do not separately bill routine follow-up care within the global period
- Staged procedure within global period: Append modifier -58 (e.g., a planned stent removal or revision after the initial ureteroenterostomy)
- Complication requiring return to OR: Append modifier -78 to the new procedure code (e.g., return for anastomotic leak repair, bowel obstruction lysis)
- Unrelated procedure during global period: Append modifier -79 to the unrelated procedure code
- Unrelated E/M visit during global period: Append modifier -24 to the E/M code
Assistant at Surgery
| Indicator | Value |
|---|---|
| Assistant at Surgery Payable | Yes - Indicator 1 |
| MD/DO Assistant Modifier | -80 - Assistant Surgeon |
| MD Assistant (No Qualified Resident) | -82 - Teaching hospital setting |
| PA-C / NP / CNS as Assistant | -AS - Medicare APP assistant at surgery |
| Co-Surgery | Not applicable |
| Team Surgery | Not applicable |
Note
Given the technical complexity and frequent need to manage both the urological and bowel components simultaneously, an assistant surgeon is clinically standard practice for CPT 50800. Medicare reimburses assistant surgeons at 16% of the primary surgeon’s allowed amount for modifier -80/-82. When modifier -AS is used for APP assistants, Medicare pays 85% of the physician rate × 85% (approximately 72% of the physician fee). Always verify commercial payer policies independently.
HCC Status & Risk Adjustment
HCC status applies to ICD-10-CM diagnosis codes — not CPT codes. Conditions commonly driving the need for ureteroenterostomy include some of the highest-weight HCC categories. Accurate and complete diagnosis coding is especially impactful for this procedure family.
| ICD-10-CM | Description | HCC Status | HCC Category | Notes |
|---|---|---|---|---|
| [[C67.9]] | Malignant neoplasm of bladder, unspecified | ✅ HCC-12 | Bladder Cancer | Most common oncologic driver for urinary diversion |
| C67.0-C67.8 | Malignant neoplasm of bladder, specific sites | ✅ HCC-12 | Bladder Cancer | Code to most specific anatomic site when documented |
| C64.1 / C64.2 | Malignant neoplasm of right / left kidney | ✅ HCC-12 | Kidney Cancer | May require ureteral diversion if ureteral involvement |
| C66.1 / C66.2 | Malignant neoplasm of right / left ureter | ✅ HCC-12 | Ureter Cancer | Direct driver of ureteroenterostomy |
| C61 | Malignant neoplasm of prostate | ✅ HCC-12 | Prostate Cancer | Bulky prostate cancer can cause ureteral obstruction |
| C79.11 / C79.19 | Secondary malignant neoplasm of kidney / other urinary organs | ✅ HCC-12 | Metastatic Cancer | Metastatic involvement of ureter |
| N13.1 | Hydronephrosis with ureteral stricture, NEC | ❌ Not HCC | — | Common non-neoplasm indication |
| N13.4 | Hydroureter | ❌ Not HCC | — | Ureteral dilation from obstruction |
| Q62.0 | Congenital hydronephrosis | ❌ Not HCC | — | Pediatric/congenital indication |
| N18.4 | CKD Stage 4 | ✅ HCC-328 | CKD | Common concurrent condition - always code |
| N18.5 | CKD Stage 5 | ✅ HCC-327 | CKD | Pre-dialysis or dialysis-dependent |
| E11.65 | Type 2 DM with hyperglycemia | ✅ HCC-37 | Diabetes | Common comorbidity affecting healing and infection risk |
| Z90.6 | Acquired absence of urinary bladder | ❌ Not HCC | — | Z-code for post-cystectomy status; important for continuity of care |
Tip
💡 Coding Tip: When a patient with bladder cancer (C67.x) undergoes ureteroenterostomy as part of or following cystectomy, the C67.x code is the HCC driver. The presence of HCC-12 (various cancers) significantly impacts the patient’s RAF score. Code all documented, clinically managed comorbidities to capture full risk. Query the physician when the operative note mentions “ureteral involvement” without specifying laterality or malignant vs. benign cause.
MS-DRG Assignment (Inpatient Facility)
MS-DRG is assigned based on the ICD-10-PCS procedure code + principal diagnosis + presence/absence of CCs and MCCs. CPT codes are used for professional billing only; inpatient facility claims use ICD-10-PCS.
ICD-10-PCS Reference for This Procedure
| ICD-10-PCS Code | Description |
|---|---|
| 0T160ZN | Bypass Right Ureter to Sigmoid Colon, Open Approach |
| 0T170ZN | Bypass Left Ureter to Sigmoid Colon, Open Approach |
| 0T180ZN | Bypass Bilateral Ureters to Sigmoid Colon, Open Approach |
| 0T160ZA | Bypass Right Ureter to Ileum, Open Approach |
| 0T170ZA | Bypass Left Ureter to Ileum, Open Approach |
| 0T180ZA | Bypass Bilateral Ureters to Ileum, Open Approach |
Note
The qualifier in ICD-10-PCS specifies the target intestinal segment (sigmoid = N, ileum = A, ascending colon = K, etc.). Accurate PCS coding requires documentation of which bowel segment is used for the anastomosis. Query the surgeon if the target bowel segment is not specified.
MS-DRG Mapping
| Clinical Scenario | MS-DRG | CC/MCC Tier | MDC |
|---|---|---|---|
| Cystectomy + Ureteroenterostomy for bladder cancer | 652 | With MCC | MDC 11 |
| Cystectomy + ureteroenterostomy for bladder cancer | 653 | With CC | MDC 11 |
| Cystectomy + ureteroenterostomy for bladder cancer | 654 | Without CC/MCC | MDC 11 |
| Ureteroenterostomy for ureteral/renal neoplasm (no cystectomy) | 659 | With MCC | MDC 11 |
| Ureteroenterostomy for ureteral/renal neoplasm (no cystectomy) | 660 | With CC | MDC 11 |
| Ureteroenterostomy for ureteral/renal neoplasm (no cystectomy) | 661 | Without CC/MCC | MDC 11 |
| Ureteroenterostomy for non-neoplasm indication | 656 | With MCC | MDC 11 |
| Ureteroenterostomy for non-neoplasm indication | 657 | With CC | MDC 11 |
| Ureteroenterostomy for non-neoplasm indication | 658 | Without CC/MCC | MDC 11 |
Note
💡 Facility Coder Note: The distinction between DRG 652-654 (Major Bladder Procedures) vs. 659-661 (Kidney/Ureter Neoplasm) vs. 656-658 (Non-Neoplasm) is driven entirely by the principal ICD-10-CM diagnosis and the ICD-10-PCS procedure. Always ensure the principal diagnosis is sequenced correctly per UHDDS guidelines (the condition chiefly responsible for the admission after workup). Capturing all documented CCs/MCCs (e.g., sepsis, CKD, respiratory failure, malnutrition) is critical for appropriate DRG assignment and reimbursement accuracy.
Common Modifiers
| Modifier | Description | When to Use with 50800 |
|---|---|---|
| -22 | Increased Procedural Services | Significantly greater complexity than typical (e.g., dense adhesions from prior pelvic radiation, redo surgery after failed prior diversion, massive tumor involvement, markedly abnormal anatomy). Requires detailed documentation and a cover letter with claim submission; payer review is common |
| -50 | Bilateral Procedure | When both right and left ureters are anastomosed to the intestine during the same operative session; report one line with modifier -50 or two lines with -RT and -LT per payer preference; second side typically reimbursed at 50% |
| -51 | Multiple Procedures | When 50800 is performed with another unrelated surgical procedure; apply to the lower-valued procedure |
| -52 | Reduced Services | Procedure started but not fully completed as described — document reason clearly |
| -53 | Discontinued Procedure | Anesthesia administered, procedure initiated, but abandoned due to patient safety concerns |
| -58 | Staged or Related Procedure | Planned return to OR during global period (e.g., planned ureteral stent removal 4-6 weeks post-op; planned second-stage reconstruction) — new global period begins |
| -59 | Distinct Procedural Service | NCCI override when a distinct, separate procedure that would normally be bundled is legitimately performed as an independent service; prefer -XE, -XS, -XP, or -XU when applicable |
| -62 | Two Surgeons (Co-Surgery) | Not typically indicated for 50800; if a colorectal surgeon and urologist co-operate independently on distinct components, verify payer policy |
| -78 | Unplanned Return to OR - Related | Return during global period for complication (anastomotic leak, bowel obstruction, hemorrhage, wound dehiscence) |
| -79 | Unrelated Procedure During Global | A completely unrelated surgical procedure performed within the 90-day global period |
| -80 | Assistant Surgeon | MD/DO assistant to the primary surgeon |
| -82 | No Qualified Resident Available | Teaching hospital setting assistant billing |
| -AS | APP as Assistant at Surgery | PA-C, NP, CNS as assistant (Medicare/most Medicaid) |
| -LT / -RT | Left / Right Side | Laterality modifiers for unilateral procedures; use when only one ureter is anastomosed |
Commonly Paired ICD-10-CM Diagnosis Codes
Always report the most specific, documented diagnosis. The following represent the most clinically relevant and commonly used diagnoses in association with CPT 50800.
| ICD-10-CM | Description | Notes |
|---|---|---|
| C67.9 | Malignant neoplasm of bladder, unspecified | 🔑 Most common oncologic indication; HCC-12 |
| C67.0 | Malignant neoplasm of trigone of urinary bladder | Use when trigone involvement documented |
| C67.1 | Malignant neoplasm of dome of urinary bladder | |
| C67.2 | Malignant neoplasm of lateral wall | |
| C67.3 | Malignant neoplasm of anterior wall | |
| C67.4 | Malignant neoplasm of posterior wall | |
| C67.5 | Malignant neoplasm of bladder neck | |
| C67.6 | Malignant neoplasm of ureteric orifice | |
| C67.8 | Malignant neoplasm of overlapping sites of bladder | |
| C66.1 | Malignant neoplasm of right ureter | Direct ureteral malignancy |
| C66.2 | Malignant neoplasm of left ureter | |
| C64.1 / C64.2 | Malignant neoplasm of right / left kidney | With ureteral involvement |
| N13.1 | Hydronephrosis with ureteral stricture, NEC | Non-neoplasm obstruction; benign indication |
| N13.4 | Hydroureter | Dilated ureter secondary to obstruction |
| N13.5 | Crossing vessel and stricture of ureter without hydronephrosis | Extrinsic compression |
| Q62.0 | Congenital hydronephrosis | Pediatric/congenital indication |
| Q62.10 | Congenital occlusion of ureter, unspecified | Congenital atresia/stenosis |
| Q62.31 | Congenital ureterocele, orthotopic | |
| N32.1 | Vesicointestinal fistula | Bladder-bowel fistula requiring diversion |
| N32.2 | Vesical fistula, NEC | Other bladder fistulae |
| S37.10XA/D/S | Unspecified injury of ureter, initial/subsequent/sequela | Traumatic ureteral disruption |
| S37.12XA | Laceration of ureter, initial encounter | |
| T81.32XA | Disruption of internal operation (surgical) wound, NEC | Post-op wound complication driving need for repair |
| Z90.6 | Acquired absence of urinary bladder | Status post-cystectomy (secondary/status code) |
| Z85.51 | Personal history of malignant neoplasm of bladder | For surveillance/follow-up encounters post-diversion |
| N18.4 / N18.5 | CKD Stage 4 / Stage 5 | Comorbidity; affects operative risk and outcome |
Coding Examples / Scenarios
Scenario 1 - Standalone Ureteroenterostomy for Ureteral Obstruction (Non-Neoplasm)
Clinical Situation: A 54-year-old male with a history of retroperitoneal fibrosis presents with bilateral hydroureter and worsening hydronephrosis. Despite prior stenting, chronic obstruction has become medically unmanageable. The urologist performs an open bilateral ureteroenterostomy, directly anastomosing both ureters to the sigmoid colon.
CPT (Professional Claim):
50800-50- Ureteroenterostomy, bilateral (modifier -50 for bilateral procedure)
ICD-10-CM:
N13.5- Crossing vessel and stricture of ureter without hydronephrosis (or N13.1 if hydronephrosis present)N13.4- Hydroureter (secondary)N18.32- CKD Stage 3b (if documented and managed)
Expected MS-DRG (Inpatient): DRG 656 - Kidney and Ureter Procedures for Non-Neoplasm with MCC (if CKD is classified as MCC), or 657 with CC, or 658 without.
✅ Modifier -50 (bilateral) is appropriate here. Some payers prefer two line items with -LT and -RT modifiers rather than a single line with -50 — verify individual payer billing guidelines.
Scenario 2 - Ureteroenterostomy Following Bladder Cancer Cystectomy (Staged; NOT Same Session)
Clinical Situation: A 67-year-old female underwent radical cystectomy (51570) for high-grade urothelial carcinoma of the bladder (C67.9) six weeks ago. Due to complications from an attempted ileal conduit, the ureteral anastomosis broke down and was left deferred. She now returns to the OR for a planned ureteroenterostomy.
CPT (Professional Claim):
50800-58- Ureteroenterostomy; modifier -58 indicates this is a staged/related procedure during the postoperative global period of the original cystectomy
ICD-10-CM:
C67.9- Malignant neoplasm of bladder, unspecified (underlying cancer driving the surgical history)N99.89- Other postprocedural complications of the genitourinary system (reason for staged return)Z90.6- Acquired absence of urinary bladder (status post prior cystectomy)
💡 Modifier -58 triggers a new 90-day global period for CPT 50800, beginning on this date of service. The original cystectomy global period does not end retroactively. Reimbursement for -58 is typically paid at 100% of the allowed fee.
Scenario 3 - Ureteroenterostomy + Bilateral Pelvic Lymphadenectomy for Bladder Cancer (Without Cystectomy)
Clinical Situation: A patient with T3 urothelial carcinoma of the bladder is deemed a poor candidate for cystectomy due to severe cardiovascular comorbidity. The urologist performs urinary diversion via direct ureteroenterostomy (bilateral ureters to sigmoid colon) plus bilateral pelvic lymphadenectomy for staging purposes. The bladder is left in situ.
CPT (Professional Claim):
50800-50- Ureteroenterostomy, bilateral38770-51- Bilateral pelvic lymphadenectomy (multiple procedure modifier)
ICD-10-CM:
C67.9- Malignant neoplasm of bladderI25.110- Atherosclerotic heart disease (comorbidity driving non-cystectomy approach)
🔍 Verify NCCI PTP edits between 50800 and 38770 before billing together. If an NCCI edit exists, modifier -59 or -XE may be required with supporting documentation of distinct services.
Scenario 4 - Increased Complexity (Modifier -22): Post-Radiation Dense Pelvic Fibrosis
Clinical Situation: A 72-year-old male presents requiring ureteroenterostomy secondary to radiation-induced bilateral ureteral strictures following external beam radiation therapy for prostate cancer 12 years ago. The operative report documents dense radiation-induced fibrosis of the pelvis, extensive adhesiolysis, prolonged operative time (6.5 hours vs. typical 2-3 hours), significant difficulty identifying ureteral planes, and need for intraoperative urology-GI co-consultation.
CPT (Professional Claim):
50800-50-22- Bilateral ureteroenterostomy with substantially increased difficulty
ICD-10-CM:
N13.5- Ureteral strictureN28.82- Megaloureter (radiation-induced dilation)Z85.46- Personal history of malignant neoplasm of prostateY84.2- Radiological procedure as the cause of abnormal reaction / late effect
Claim Submission:
📝 When billing modifier -22, attach a cover letter explaining the extraordinary circumstances, the specific additional work involved (time, difficulty, technique), and reference the operative report. Many payers require prior authorization or manual review for -22 claims. Expected additional reimbursement: typically 20-30% above standard fee if approved.
Scenario 5 - Complication: Return to OR for Anastomotic Leak (Modifier -78)
Clinical Situation: On post-op day 7 following ureteroenterostomy, the patient develops peritonitis and imaging confirms an anastomotic leak at the ureteroenteric junction. The surgeon returns the patient to the OR for open exploration and repair of the anastomotic disruption.
CPT (Professional Claim for Return to OR):
50800-78- Ureteroenterostomy (revision/repair); modifier -78 indicates unplanned return to OR for related complication within the global period
ICD-10-CM:
N99.89- Other postprocedural complications of genitourinary systemK63.2- Fistula of intestine (if applicable to anastomotic breakdown pattern)K65.0- Generalized (acute) peritonitis
⚠️ Modifier -78 reduces reimbursement to the facility component only (intraoperative and immediate postoperative care). A new global period does NOT begin with modifier -78.
Scenario 6 - Inpatient Facility Coding (ICD-10-PCS + DRG Optimization)
Clinical Situation: A 61-year-old male is admitted for open ureteroenterostomy (right ureter to sigmoid colon) for urothelial carcinoma of the right ureter (C66.1). He also has CKD Stage 4 (N18.4) and type 2 diabetes with diabetic CKD (E11.65).
ICD-10-CM (Inpatient Sequencing):
C66.1- Malignant neoplasm of right ureter (principal diagnosis — reason for admission)N18.4- CKD Stage 4 (CC/MCC — verify DRG grouper version)E11.65- Type 2 DM with hyperglycemia (CC)N13.4- Hydroureter (secondary to ureteral malignancy)
ICD-10-PCS:
0T160ZN- Bypass Right Ureter to Sigmoid Colon, Open Approach
Expected MS-DRG:
659- Kidney and Ureter Procedures for Neoplasm with MCC (if CKD Stage 4 classifies as MCC in current grouper version — verify)- OR
660- with CC (if CKD Stage 4 = CC tier only)
💡 Facility Coding Impact: The difference between DRG 659 (with MCC) and DRG 660 (with CC) can be significant in terms of facility payment weight. Accurate documentation and coding of CKD Stage 4 and diabetes with its specific manifestation directly affects DRG tier assignment. Query the attending physician for CKD staging details and for confirmation that diabetes with CKD is being clinically managed during this admission.
Scenario 7 - Surgical Pathology (Add-On Billing)
Clinical Situation: Following ureteroenterostomy for ureteral carcinoma, resected ureteral tissue and any regional lymph nodes are submitted to surgical pathology.
Pathology Charges (Separately Billable by Pathology):
88307- Surgical pathology, gross and microscopic examination - Ureter (resection)88305- Surgical pathology - lymph nodes (regional)
✅ Pathology charges are not bundled into CPT 50800 and are separately billable by the pathology group/physician when a specimen is submitted. 88307 (vs. 88305) is appropriate for a resection specimen of the ureter with malignancy.
Documentation Requirements
To support medical necessity, accurate billing, and audit defense for CPT 50800, the operative report should explicitly include:
- Clinical indication: Clearly documented medical necessity (malignancy, obstruction, fistula, etc.)
- Approach: Open (laparotomy) — confirm open vs. laparoscopic (there are no distinct CPT codes for laparoscopic ureteroenterostomy; use unlisted code 50949 if robotic/laparoscopic)
- Laterality: Right, left, or bilateral ureteral anastomosis
- Target bowel segment: Sigmoid colon, ileum, ascending colon, etc. (required for accurate ICD-10-PCS coding)
- Anastomotic technique: Direct mucosa-to-mucosa, anti-reflux technique, etc.
- Ureteral stent placement: Confirm whether temporary stents were placed across anastomosis
- Extent of ureteral mobilization: Document any lysis/adhesiolysis performed
- Hemostasis and drain placement
- Associated procedures performed during same session (lymphadenectomy, cystectomy, bowel resection) — clearly describe each
- Estimated blood loss
- Complications if any
- Specimen disposition: Tissue sent to pathology — confirm specimen types and laterality
- Postoperative condition and catheter/drain details
Note
⚠️ If the approach is laparoscopic or robotic, CPT 50800 is NOT the correct code. CPT 50800 is defined as an open procedure. For laparoscopic/robotic ureteroenterostomy, use the unlisted laparoscopic ureter procedure code (50949) with a cover letter describing the procedure in detail.
Coding Tips & Pitfalls
💡 Do NOT stack 50800 with cystectomy codes. When a cystectomy and urinary diversion are performed together in the same operative session, use the combined cystectomy-diversion codes (51590, 51595, 51596). These are all-inclusive codes. Reporting 50800 + 51570 or 51575 for the same session constitutes unbundling per NCCI.
💡 Know the difference between 50800, 50810, and 50820. All three describe ureter-to-bowel anastomosis, but they differ critically: 50800 = direct ureter to native intestine (sigmoid most common); 50810 = ureterocolon conduit using sigmoid as a passive reservoir; 50820 = ureteroileal conduit (Bricker), isolated ileal segment as a conduit to a cutaneous stoma. The operative note must be read carefully to determine which bowel segment was used, whether it was isolated or native, and whether a cutaneous stoma was created.
💡 Bilateral modifier -50 vs. -LT/-RT. When both ureters are anastomosed, modifier -50 (bilateral) is appropriate. However, some Medicare Administrative Contractors (MACs) and commercial payers prefer two separate line items with -LT and -RT. Always check your specific MAC’s Local Coverage Article and your payer contracts for billing preference.
💡 Laparoscopic/robotic approach = unlisted code. As minimally invasive surgery becomes more common even for complex urinary diversions, be aware that CPT 50800 does NOT apply to robotic or laparoscopic approaches. Use 50949 (Unlisted laparoscopic procedure, ureter) with a detailed cover letter for robotic/laparoscopic cases.
💡 Z90.6 is your friend. When a patient returns for follow-up or has subsequent encounters post-cystectomy, always include
Z90.6(Acquired absence of urinary bladder) in the diagnosis coding. This code supports continuity of care documentation, aids in clinical decision-making for future encounters, and ensures proper claims context.
💡 Metabolic acidosis as a CC. Post-ureteroenterostomy hyperchloremic metabolic acidosis (E87.2 - Acidosis) may qualify as a CC in the inpatient DRG context. Ensure the attending physician documents and addresses this condition if clinically present, and code it when documented.
💡 ICD-10-PCS qualifier specificity matters. In the inpatient ICD-10-PCS coding, the qualifier (target intestinal segment) changes the code. Assigning the wrong qualifier (e.g., ileum vs. sigmoid colon) is a coding error that could affect MS-DRG assignment and potentially result in a compliance finding. Always reference the operative report for the specific bowel segment used.